首页> 美国卫生研究院文献>Journal of Nuclear Medicine Technology >Comparison of Performance of Improved Serum Estimators of Glomerular Filtration Rate (GFR) to 99mTc-DTPA GFR Methods in Patients with Hepatic Cirrhosis
【2h】

Comparison of Performance of Improved Serum Estimators of Glomerular Filtration Rate (GFR) to 99mTc-DTPA GFR Methods in Patients with Hepatic Cirrhosis

机译:改进的肾小球滤过率血清估计值(GFR)与99mTc-DTPA GFR方法在肝硬化患者中的性能比较

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Glomerular filtration rate (GFR) measurements are critical in patients with hepatic cirrhosis but potentially erroneous when based on serum creatinine. New equations for estimated GFR (eGFR) have shown variable performance in cirrhotics, possibly because of inaccuracies in reference methods for measured GFR (mGFR). The primary objective was to compare the performance of 4 improved eGFR equations with a 1-compartment, 2-sample plasma slope intercept 99mTc-DTPA mGFR method to determine whether any of the eGFR calculations could replace plasma 99mTc-DTPA mGFR in patients with cirrhosis. The secondary objective was to test the hypothesis that mGFR using voluntary voided urine collections introduces error compared with plasma-only methods. >Methods: Fifty-four patients with hepatic cirrhosis underwent mGFR determinations from 2 plasma samples at 1 and 3 h after intravenous administration of 185 MBq of 99mTc-DTPA. GFR was also generated by a UV/P calculation derived from blood and urine samples. These mGFRs were compared with the eGFRs generated by 4 estimating equations: MDRD (Modified Diet in Renal Disease), CKD-EPI (Chronic Kidney Disease-Epidemiology Collaboration) (serum creatinine [SCr]), CKD-EPI (cystatin [CysC]), and CKD-EPI (CysC+SCr). eGFRs were compared with mGFRs by Pearson correlation, precision, bias, percentage bias, and accuracy (eGFRs varying by <10% [p10], <20% [p20] or <30% [p30] from the corresponding mGFR). >Results: All eGFRs showed poorer performance when the UV/P 99mTc-DTPA mGFR was used as the reference than when the plasma 99mTc-DTPA mGFR was used. When compared with the plasma 99mTc-DTPA mGFR method, the performance of all eGFR equations was superior to most published reports. There was a moderately good positive correlation between eGFRs and mGFRs. When compared with plasma 99mTc-DTPA mGFR, precision of eGFRs was in the range of 14–20 mL/min and showed a negligible bias. Compared with the plasma 99mTc-DTPA mGFR, CKD-EPI (CysC+SCr) showed the best overall performance and accuracy, at 85.19% (p30), 75.93% (p20), and 42.59% (p10). >Conclusion: Estimating equations for measuring eGFR performed better than in most published reports, attributable to use of the plasma 99mTc-DTPA mGFR method as a reference. CKD-EPI (CysC+SCr) eGFR showed the best overall performance. However, more discriminating methods may be required when accurate GFR measurements are necessary. mGFR measurements using urine collections may introduce error compared with plasma-only methods.
机译:肾小球滤过率(GFR)的测量对肝硬化患者至关重要,但根据血清肌酐水平可能存在错误。估计的GFR(eGFR)的新方程式显示了肝硬化患者的可变表现,这可能是因为测量GFR(mGFR)的参考方法不准确。主要目的是比较4个改进的eGFR方程与1室,2样品血浆斜率截距 99m Tc-DTPA mGFR方法的性能,以确定是否有任何eGFR计算可以代替血浆< sup> 99m Tc-DTPA mGFR在肝硬化患者中的作用。第二个目的是检验以下假设:与仅使用血浆的方法相比,使用自愿排尿收集的mGFR会引入误差。 >方法:在静脉内施用 99m Tc-DTPA 185 MBq后的1和3小时,对2例血浆样本中的54例肝硬化患者进行了mGFR测定。 GFR也是通过从血液和尿液样本得出的UV / P计算得出的。将这些mGFR与通过4个估计方程式生成的eGFR进行比较:MDRD(肾脏疾病的改良饮食),CKD-EPI(慢性肾脏病-流行病学协作)(血清肌酐[SCr]),CKD-EPI(胱抑素[CysC]) ,以及CKD-EPI(CysC + SCr)。通过皮尔逊相关性,精确度,偏差,偏差百分比和准确性(eGFR与相应的mGFR相比,变化<10%[p10],<20%[p20]或<30%[p30]),将eGFR与mGFR进行了比较。 >结果:当使用UV / P 99m Tc-DTPA mGFR作为参考时,所有eGFR的性能都比血浆 99m Tc-使用了DTPA mGFR。与血浆 99m Tc-DTPA mGFR方法相比,所有eGFR方程的性能均优于大多数已发表的报告。 eGFR和mGFR之间存在中等程度的正相关。与血浆 99m Tc-DTPA mGFR相比,eGFR的精确度在14–20 mL / min范围内,并且偏差可忽略不计。与血浆 99m Tc-DTPA mGFR相比,CKD-EPI(CysC + SCr)表现出最佳的整体性能和准确性,分别为85.19%(p30),75.93%(p20)和42.59%(第10页)。 >结论:由于使用血浆 99m Tc-DTPA mGFR方法作为参考,因此估算eGFR的方程式比大多数已发表的报告要好。 CKD-EPI(CysC + SCr)eGFR显示出最佳的整体性能。但是,当需要精确的GFR测量时,可能需要更多区分方法。与仅使用血浆的方法相比,使用尿液收集器进行的mGFR测量可能会引入误差。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号